EML4-ALK (echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase) is a common RTK fusion that drives ~5–7% of non-small cell lung cancer (NSCLC)2–4. This evidence concerns the gene ALK and non-small cell lung carcinoma.